Understanding: Videos and Talks
Develop Your Understanding
Listen to these pioneering discussions to hear more about the potential of psychedelic medicines.
Roland R. Griffiths, Ph.D - Johns Hopkins
The science of psilocybin and its use to relieve suffering
Leading psychopharmacologist Dr Roland Griffiths discloses the ways that psychedelic drugs can be used to create spiritually meaningful, personally transformative experiences for all patients, especially the terminally ill.
Rick Doblin. Ph.D - Executive Director of MAPS
The Promise of Psychedelics for PTSD - Oslo Freedom Forum
Rick Doblin has committed his life to researching the use of psychedelics and marijuana to treat post-traumatic stress disorder (PTSD). Conventional treatments like anti-depressants are only effective for 40-60% of patients suffering from PTSD. Doblin explains the toll the disorder takes on the human rights community, and recent developments that will embolden research into alternative treatments.
Robin Carhart-Harris Ph.D - Imperial College London
Psychedelics: Lifting the veil
Robin has been conducting pioneering brain imaging studies of psychedelic drugs. Most recently, he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat depression, and his talk looks at how these drugs can be used in treatment. After completing his PhD at the University of Bristol in 2009, Robin moved to Imperial College London, where he has worked for the last few years on the brain effects of LSD, psilocybin (magic mushrooms) and MDMA, conducting some pioneering brain imaging studies of these drugs. Most recently he has completed the first phase of a clinical trial looking at the potential of psilocybin to treat major depression.
Stephen Bright Ph.D - Vice President of PRISM
The Psychedelic Renaissance
Psychedelic drugs: a dangerous and illegal scourge; a harmless way to “turn on, tune in, drop out” – or a valuable treatment for mental illness? Research is showing that substances like MDMA and magic mushrooms, long banished to society’s fringes, are proving effective in treating everything from PTSD to nicotine addiction. In this talk, Stephen Bright explores the recent re-emergence of psychedelic science and discusses why this field is absent from the Australian research landscape. Dr Stephen Bright is a clinically-trained psychologist. He is a Senior Lecturer of Addiction at Edith Cowan University in Perth and a founding board member of PRISM, an Australian not-for-profit set up to advance the cause of psychedelic research.